Nascent Biotech, Inc. NBIO
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.0005 Day range 0.0005
0.0001 52-week range 0.084
- YTD
- -66.67%
- 1 year
- -91.30%
- Open
- 0.0005
- Prev close
- 0.0002
- Mkt cap
- 34.44K
- Vol
- 15.00K
- Avg vol
- 22.23K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0005
- High
- 0.0005
2Y chart
Signals (57)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 10, 2026 | 1 month ago |
| RSI: Oversold | Sep 10, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 9, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 7, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| RSI: Overbought | May 21, 2026 | 5 months ago |
| SMA: Bullish | May 8, 2026 | 5 months ago |
| MACD: Buy Signal | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| RSI: Oversold | Apr 29, 2026 | 6 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 18, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| RSI: Overbought | Nov 11, 2025 | 11 months ago |
| RSI: Oversold | Nov 7, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 14, 2025 | 1 year ago |
| RSI: Oversold | Oct 14, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| RSI: Overbought | Sep 10, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 9, 2025 | 1 year ago |
| RSI: Oversold | Sep 4, 2025 | 1 year ago |
| SMA: Bearish | Aug 15, 2025 | 1 year ago |
| RSI: Oversold | Aug 14, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 11, 2025 | 1 year ago |
| RSI: Overbought | Jul 11, 2025 | 1 year ago |
| RSI: Oversold | May 20, 2025 | 1 year ago |
| MACD: Buy Signal | May 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 11, 2025 | 1 year ago |
| RSI: Oversold | Apr 11, 2025 | 1 year ago |
| SMA: Bullish | Mar 28, 2025 | 1 year ago |
| RSI: Oversold | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| RSI: Oversold | Jan 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 31, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 23, 2024 | 1 year ago |
News
- Nascent Biotech (OTCMKTS:NBIO) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?
- Nascent Biotech Presents at the July Emerging Growth Conference
- Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
- Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System
- Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
- Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
- Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
- Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier
- Nascent Biotech to Begin Phase II Clinical Trials for Brain Cancer
- Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual Meeting
Your note
Sign in to keep a note on NBIO — it syncs with the Stock Master app.